Renaissance Capital logo

GRVI News

US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week

DOCS

16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate (SSR). Doximity (DOCS) priced above the range to raise...read more

CBD products maker Grove prices IPO at $5 midpoint

GRVI

Grove, which makes and sells CBD products, raised $11 million by offering 2.2 million shares at $5, within the range of $4.50 to $5.50. At pricing, the company commands a fully diluted market value of $79 million. Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol...read more

CBD products maker Grove sets terms for $11 million IPO

GRVI

Grove, which makes and sells CBD products, announced terms for its IPO on Friday. The Henderson, NV-based company plans to raise $11 million by offering 2.2 million shares at a price range of $4.50 to $5.50. At the midpoint of the proposed range, Grove would command a fully diluted market value of $79 million. Grove develops, produces, markets, and sells raw materials...read more

US IPO Weekly Recap: Coinbase’s direct listing headlines a 9 IPO week

COIN

The IPO market revved back to life with nine IPOs raising $5.4 billion, joined by crypto exchange Coinbase’s direct listing. SPAC activity continued to decline, with just two raising $700 million. Pipeline activity held steady, with 10 IPOs, six SPACs, and one direct listing submitting initial filings. The first major direct listing on the Nasdaq, ...read more